Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Alphabet's Google Reportedly to Cut Search Access for Schools That Restrict AI

Alphabet's Google Reportedly to Cut Search Access for Schools That Restrict AI

MT newswireMT newswire2026/11/03 16:34
12:34 PM EST, 11/03/2026 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google has told schools seeking to fully restrict access to AI tools that they will also lose access to Google Search, multiple media outlets reported Tuesday. Search and AI are now deeply integrated, meaning schools cannot fully restrict AI tools while retaining access to Search, the reports said, citing Chris Phillips, vice president for education at Google. Google said Tuesday it was updating Google Search and Google Classroom with Guided Learning capabilities, which help primary and secondary school students work through problems without "skipping straight to answers." Google did not immediately reply to a request for comment from MT Newswires. Price: 278.95, Change: +0.91, Percent Change: +0.33
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss